SurgePays
SURG
#10950
Rank
C$12.21 M
Marketcap
C$0.20
Share price
-2.25%
Change (1 day)
-92.69%
Change (1 year)

P/E ratio for SurgePays (SURG)

P/E ratio as of November 2026 (TTM): -0.1157

According to SurgePays's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.115667. At the end of 2025 the company had a P/E ratio of -0.9389.

P/E ratio history for SurgePays from 2018 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-0.938926.78%
2024-0.7406-116.65%
20234.45-103.39%
2022-13118756.19%
2021-0.6958-42.74%
2020-1.22-62.42%
2019-3.23-84.71%
2018-21.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
40.0-34,675.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
28.8-25,002.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Stryker Corporation
SYK
33.1-28,742.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
20.2-17,606.89%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
19.2-16,669.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
82.2-71,201.35%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.